Unio Capital’s Pfizer PFE Stock Holding History

Unio Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5,174	Closed	-$211K	–	43
2023 Q1	$211K	Hold	5,174	–	–	0.11%	40
2022 Q4	$265K	Sell	5,174 -1,587	-23%	-$76.1K	0.15%	39
2022 Q3	$296K	Hold	6,761	–	–	0.18%	38
2022 Q2	$354K	Sell	6,761 -3,901	-37%	-$199K	0.2%	40
2022 Q1	$552K	Hold	10,662	–	–	0.24%	39
2021 Q4	$630	Hold	10,662	–	–	﹤0.01%	38
2021 Q3	$459K	Hold	10,662	–	–	0.2%	36
2021 Q2	$418K	Buy	+10,662	New	+$415K	0.19%	37
2018 Q4	–	Sell	-5,217	Closed	-$218K	–	75
2018 Q3	$218K	Buy	+5,217	New	+$201K	0.14%	70
2018 Q1	–	Sell	-8,590	Closed	-$295K	–	83
2017 Q4	$295K	Buy	+8,590	New	+$293K	0.25%	68

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Unio Capital's PFE Position: Q2 2023 in Review

Unio Capital sold out of Pfizer (PFE) in Q2 2023, closing a stake of 5,174 shares — an estimated $211K sold.

Unio Capital first reported a position in PFE in Q4 2017 and held it in 10 quarters. The position peaked at $552K in Q1 2022. 3,041 funds tracked by Wall St. Rank hold PFE as of Q2 2023.

Unio Capital reported no remaining Pfizer position as of Q2 2023 after selling out during the quarter.
Unio Capital sold 5,174 Pfizer shares in Q2 2023, an estimated $211K.
Unio Capital first reported a position in Pfizer in Q4 2017 and held it in 10 quarters.
Unio Capital's Pfizer position peaked at $552K in Q1 2022.
3,041 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.

Based on Unio Capital's 13F filing for Q2 2023, filed 14 Aug 2023.